These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14740950)

  • 1. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.
    Eckels KH; Dubois DR; Putnak R; Vaughn DW; Innis BL; Henchal EA; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):12-6. PubMed ID: 14740950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.
    Kanesa-Thasan N; Edelman R; Tacket CO; Wasserman SS; Vaughn DW; Coster TS; Kim-Ahn GJ; Dubois DR; Putnak JR; King A; Summers PL; Innis BL; Eckels KH; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):17-23. PubMed ID: 14740951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii.
    Halstead SB; Marchette NJ
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):5-11. PubMed ID: 14740949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.
    Halstead SB; Diwan AR; Marchette NJ; Palumbo NE; Srisukonth L
    Am J Trop Med Hyg; 1984 Jul; 33(4):654-65. PubMed ID: 6476212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.
    Edelman R; Tacket CO; Wasserman SS; Vaughn DW; Eckels KH; Dubois DR; Summers PL; Hoke CH
    J Infect Dis; 1994 Dec; 170(6):1448-55. PubMed ID: 7995984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R
    Am J Trop Med Hyg; 1984 Jul; 33(4):666-71. PubMed ID: 6476213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys.
    Angsubhakorn S; Yoksan S; Bhamarapravati N; Moe JB; Marchette NJ; Pradermwong A; Sahaphong S
    Trans R Soc Trop Med Hyg; 1988; 82(5):746-9. PubMed ID: 3252595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. I. Pre-clinical studies.
    Marchette NJ; Dubois DR; Larsen LK; Summers PL; Kraiselburd EG; Gubler DJ; Eckels KH
    Am J Trop Med Hyg; 1990 Aug; 43(2):212-8. PubMed ID: 1975159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R; Larsen LK
    Am J Trop Med Hyg; 1984 Jul; 33(4):672-8. PubMed ID: 6476214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques.
    Añez G; Men R; Eckels KH; Lai CJ
    J Virol; 2009 Oct; 83(20):10384-94. PubMed ID: 19656873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells.
    Eckels KH; Scott RM; Bancroft WH; Brown J; Dubois DR; Summers PL; Russell PK; Halstead SB
    Am J Trop Med Hyg; 1984 Jul; 33(4):684-9. PubMed ID: 6476216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate.
    Kelly EP; Puri B; Sun W; Falgout B
    Vaccine; 2010 Apr; 28(17):3030-7. PubMed ID: 19874927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.
    Puri B; Nelson WM; Henchal EA; Hoke CH; Eckels KH; Dubois DR; Porter KR; Hayes CG
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2287-91. PubMed ID: 9292016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys.
    Lin HH; Lee HC; Li XF; Tsai MJ; Hsiao HJ; Peng JG; Sue SC; Qin CF; Wu SC
    PLoS One; 2014; 9(6):e100130. PubMed ID: 24959738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of viraemia and limited antibody response of dengue virus immune rhesus monkeys after vaccination with DEN-2/S-1 vaccine.
    Kraiselburd E; Kessler MJ; Torres-Blasini G
    Trans R Soc Trop Med Hyg; 1984; 78(4):445-8. PubMed ID: 6548325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.